Using conventional fluorescent and light-sheet fluorescent microscopy, we show that two doses of intratumoral IL-15 complexes coupled with anti-PD-1 mAb reach the tumor-draining lymph node, where they can engage CD8+ T cells and other immune cells, resulting in their activation. The gene discussed is CD8A; the disease is neoplasm.